Lerman Bradley E Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$23.88M

Insider Activity of Lerman Bradley E

According to the SEC Form 4 filings, Lerman Bradley E, being in a position of

  1. director at McKesson Corporation,
    оver the last 12 months, has bought 0 shares, and sold 301 share for $268,590,
    over all time since 2026-08-10, has bought 0 shares, and sold 301 share for $268,590.

Biography of Lerman Bradley E

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $268,5901100

Comparison of Insiders on Amount of Buys and Sells

2026-08-10SaleMcKesson Corporation
MCK
director
301
0.0003%
$892.33$268,590+2.42%
2021-09-30SaleMedtronic plc
MDT
SVP General Counsel & Corp Sec
49,147
0.0037%
$126.58$6.22M-16.5%
2021-08-31SaleMedtronic plc
MDT
SVP General Counsel & Corp Sec
50,775
0.0038%
$134.17$6.81M-20.23%
2021-08-02SaleMedtronic plc
MDT
SVP General Counsel & Corp Sec
4,000
0.0003%
$131.52$526,080-17.33%
2020-12-22SaleMedtronic plc
MDT
SVP General Counsel & Corp Sec
5,210
0.0004%
$115.56$602,068+8.57%
2020-11-09SaleMedtronic plc
MDT
SVP General Counsel & Corp Sec
41,430
0.0031%
$113.13$4.69M+10.47%
2020-10-08SaleMedtronic plc
MDT
SVP General Counsel & Corp Sec
20,714
0.0009%
$64.58$1.34M+14.21%
2019-08-05SaleMedtronic plc
MDT
SVP General Counsel & Corp Sec
8,000
0.0006%
$100.31$802,480+6.5%
2019-08-02SaleMedtronic plc
MDT
SVP General Counsel & Corp Sec
13,198
0.001%
$102.02$1.35M+3.65%
2018-06-11SaleMedtronic plc
MDT
SVP General Counsel & Corp Sec
17,820
0.0013%
$86.82$1.55M+6.28%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.